Search

Anindita Mukerjee

from Frisco, TX
Age ~45
Get Report
Also known as:
Mukerjee Anindita
Related to:
Shyamal Mukerjee
Connected to:
Mamta S Mukerjee, 57Neiloy Mukerjee, 34Sandeep Mukerjee, 63Subir Mukerjee, 73Chipli Mukerji, 43Dipesh K Mukerji, 45Nayantara Mukerji, 53Siddharth S Mukerji, 49Erika Mukes, 48Ronald T Mukes, 50

Anindita Mukerjee Phones & Addresses

  • Frisco, TX
  • Fort Worth, TX

Work

Company: Alcon, a novartis company Feb 2016 to Jan 2017 Position: Global regulatory affairs labeling manager

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Doms, Iit Roorkee 1999 to 2008 Specialities: Philosophy

Industries

Pharmaceuticals

Resumes

Resumes

Anindita Mukerjee Photo 1

Regulatory Affairs Global Labeling Manager

View page
Location:
Fort Worth, TX
Industry:
Pharmaceuticals
Work:
Alcon, A Novartis Company Feb 2016 - Jan 2017
Global Regulatory Affairs Labeling Manager
Novartis Feb 2016 - Jan 2017
Regulatory Affairs Global Labeling Manager
Unt Health Science Center (Unthsc) Oct 2013 - Feb 2016
Co-Director of Education Core; Texas Center For Health Disparities
Unt Health Science Center (Unthsc) Mar 2008 - Oct 2013
Post Doc
Education:
Doms, Iit Roorkee 1999 - 2008
Doctorates, Doctor of Philosophy, Philosophy University Institute of Pharmaceutical Sciences 1998 - 2002
Bachelors, Bachelor of Pharmacy, Pharmacy

Publications

Us Patents

Solid In Oil/Water Emulsion-Diffusion-Evaporation Formulation For Preparing Curcumin-Loaded Plga Nanoparticles

View page
US Patent:
20100290982, Nov 18, 2010
Filed:
Apr 23, 2010
Appl. No.:
12/766068
Inventors:
Amalendu Prakash Ranjan - Fort Worth TX, US
Anindita Mukerjee - Fort Worth TX, US
Jamboor K. Vishwanatha - Fort Worth TX, US
Assignee:
University of North Texas Health Science Center at Fort Worth - Fort Worth TX
International Classification:
A61K 51/02
A61K 31/713
A61K 39/395
A61K 31/121
A61P 35/00
A61P 31/10
A61P 31/12
A61P 33/10
A61P 31/00
US Classification:
424 111, 514 44 A, 4241301, 514679, 977773, 977906, 977882
Abstract:
The present invention includes compositions and methods of making an activated polymeric nanoparticle for targeted drug delivery that includes a biocompatible polymer and an amphiphilic stabilizing agent non-covalently associated with a spacer compound that includes at least one electrophile that selectively reacts with any nucleophilic on a targeting agent and places the targeting agent on the exterior surface of a biodegradable nanoparticle, wherein an active agent is encapsulated in or about the nanoparticle.
Control profile
Anindita Mukerjee from Frisco, TX, age ~45 Get Report